FY2025 · ended Dec 31, 2025 · Revenue $0, -100.0% YoY · Filed Mar 24, 2026
Fractyl Health, Inc. (GUTS) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $0 and a net loss of $141.0 million. Free cash flow was -$90.9 million. As of Jun 30, 2026 it held $47.1 million in cash and investments and $30.3 million in total debt.
Revenue
$0
-100.0% vs prior year
Net income
$-140.95M
-105.2% vs prior year
Operating cash flow (TTM)
$-82.43M
-1.3% vs year-ago TTM
Free cash flow
$-90.89M
-35.1% vs prior year
EPS
$-1.86
-14.8% vs prior year
Dividend per share
None
Shares outstanding
158.65M
+224.3% vs prior year
Net cash
$16.85M
as of Jun 30, 2026
Operating margin
-100571.0%
FY 2024
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- GUTS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Burlington, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1572616
- Former names
- Fractyl Laboratories Inc. (until Mar 19, 2020)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
|---|---|---|
| Revenue | $0 | $93,000 |
| Operating income | -$96.8M | -$93.5M |
| Net income | -$141.0M | -$68.7M |
| Diluted EPS | -$1.86 | -$1.62 |
| Operating cash flow | -$90.3M | -$65.5M |
| Free cash flow | -$90.9M | -$67.3M |
| Total assets | $121.4M | $108.1M |
| Total liabilities | $111.9M | $79.7M |
| Stockholders' equity | $9.5M | $28.4M |
| Cash and investments | $81.5M | $67.5M |
| Total debt | $31.1M | $32.3M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Exit or restructuring costs, Officer or director change, Other events
|
Oct 22, 2026 | Oct 21, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 16, 2026 | Oct 16, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 1, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Sep 24, 2026 | Sep 24, 2026 |
| 8-K |
Current report
Listing notice
|
Sep 11, 2026 | Sep 10, 2026 |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
All 227 Fractyl Health, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.